Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
551.8 INR | +16.45% | +31.67% | +52.78% |
Sales 2024 * | 14.31B 171M | Sales 2025 * | 17.07B 204M | Capitalization | 17.06B 204M |
---|---|---|---|---|---|
Net income 2024 * | -3.21B -38.46M | Net income 2025 * | 293M 3.51M | EV / Sales 2024 * | 1.19 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
58.1
x | Employees | 2,361 |
Yield 2024 * |
-
| Yield 2025 * |
0.63% | Free-Float | 43% |
Latest transcript on Solara Active Pharma Sciences Limited
1 day | +12.04% | ||
1 week | +29.11% | ||
Current month | +43.11% | ||
1 month | +43.76% | ||
3 months | +29.62% | ||
6 months | +59.80% | ||
Current year | +46.99% |
Managers | Title | Age | Since |
---|---|---|---|
Poorvank Purohit
CEO | Chief Executive Officer | - | 23-02-02 |
Sudhir Nambiar
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 52 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arun N. Kumar
BRD | Director/Board Member | 63 | - |
Chief Operating Officer | 52 | 18-12-31 | |
Director/Board Member | 40 | 19-05-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | -1.38% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 551.8 | +16.45% | 6 454 379 |
24-04-18 | 473.8 | +11.97% | 3,111,681 |
24-04-16 | 423.2 | +6.45% | 536,274 |
24-04-15 | 397.5 | -3.32% | 120,945 |
24-04-12 | 411.2 | -1.89% | 121,810 |
Delayed Quote NSE India S.E., April 19, 2024 at 04:52 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.99% | 204M | |
+27.97% | 672B | |
+23.56% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+1.83% | 211B | |
-0.66% | 203B | |
-10.39% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- SOLARA Stock